ADAMTS13 and thrombotic thrombocytopenic purpura: Analyzing the comprehension of “what is the risk of relapse and what triggers TTP?” (Q26–Q32; Fig. 1) clearly shows that more than 78% of the patients knew that a regular medical follow up is needed to prevent relapse and that this is linked with ADAMTS13 activity (Q29–Q31).